新关注 > 信息聚合 > FDA批准诺华免疫治疗药物艾曲波帕用于ITP儿科

FDA批准诺华免疫治疗药物艾曲波帕用于ITP儿科

FDA approved Novartis immunotherapy drug eltrombopag for ITP pediatric

2015-06-16 10:22:03来源: 医药网

医药网6月16日讯 医药行业两大巨头诺华(Novartis)与葛兰素史克(GSK)价值220亿美元的资产置换交易于今年3月初圆满完成。其中,诺华以160亿美元收购葛兰素史克的肿瘤业务,使其在全球肿瘤...

net of medicine of the June 16 hearing pharmaceutical industry two giant Novartis (NVS) and GlaxoSmithKline (GSK) value $220 billion asset exchange transaction in early March this year, the successful completion of the. Among them, Novartis's $16000000000 acquisition of GSK's Oncology business, the tumor in the world...